Momenta Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
$10M milestone payment from Sandoz earned for the second anniversary of Glatopa® 20 mg as the sole FDA-approved generic on the market for patients with relapsing forms of multiple sclerosis Ended second quarter with a strong cash position of $457M …